Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × HER2-positive Breast Cancer × Leuprolide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 72 Breast Neoplasms 7 Neoplasms 5 Polycystic Ovary Syndrome 2 Neoplasm Metastasis 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Recurrence 1 Prostatic Diseases 1 Prostate Adenocarcinoma 1 Premenopausal Breast Cancer 1 PSA Level Greater Than Two 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms, Glandular and Epithelial 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Metabolic Syndrome 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphatic Metastasis 1 Lower Urinary Tract Symptoms 1 Leukemia, Myeloid, Acute 1 Leiomyoma 1 Insulin Resistance 1 Infertility 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Glucose Intolerance 1

Interventions

pertuzumab 2 Trastuzumab 2 Docetaxel 2 tucatinib 1 Protons 1 Paclitaxel 1 Fulvestrant 1 Enfuvirtide 1 Doxorubicin 1 Cyclophosphamide 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡